Crittenden, M., Bahjat, K. S., Li, R., Gore, P., Fountain, C., Hanson, B., . . . Urba, W. (2015). Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas. J Immunother Cancer.
Citação norma ChicagoCrittenden, Marka, et al. "Phase I Study of Safety and Immunogenicity of ADU-623, a Live-attenuated Listeria Monocytogenes Vaccine (ΔactA/ΔinlB) Expressing EGFRVIII and NY-ESO-1, in Patients With Who Grade III/IV Astrocytomas." J Immunother Cancer 2015.
Citação norma MLACrittenden, Marka, et al. "Phase I Study of Safety and Immunogenicity of ADU-623, a Live-attenuated Listeria Monocytogenes Vaccine (ΔactA/ΔinlB) Expressing EGFRVIII and NY-ESO-1, in Patients With Who Grade III/IV Astrocytomas." J Immunother Cancer 2015.